Summary The covalent binding of a carotene moiety to one phenyl ring and meso-tetraphenyl-substituted porphyrins (see Figure 1 ) efficiently quenches the photosensitising activity of the porphyrin while a relatively large yield of fluorescence emission around 650 nm is retained. Pharmacokinetic studies performed with two carotenoporphyrins (CPs) and the corresponding porphyrins (Ps) in Balb/c mice bearing an MS-2 fibrosarcoma show that the two Ps give a high selectivity of tumour localisation (tumour/peritumoral tissue ratios of dye concentration ranging between c. 30 and 90 at 24 h after injection of 4.2 -8.4 1tmol kg-in a Cremophor emulsion) and photosensitise tumour necrosis upon red light irradiation. For the same injected doses, the two CPs show no tumour-photosensitising activity even though they localise in the tumour in concentrations of the order of 10-40 jug g-' at 24 h with tumour/peritumoral ratios larger than 10. Thus, the fluorescence emitted by these CPs in the tumour can be used for photodiagnostic purposes with no risk of skin photosensitisation. However, this approach is presently limited by the large accumulation and prolonged retention of the CPs in the liver and spleen.
The observation that some porphyrins and their analogues are accumulated in significant amounts and retained for prolonged periods of time by a variety of solid tumours (Zhou, 1989; Marcus, 1992) has opened new prospects for the therapy of neoplastic lesions by taking advantage of the photosensitising properties of many tetrapyrrolic compounds (Jori & Spikes, 1984) , as well as for the early diagnosis of such lesions based on the fluorescence emission typical of the porphyrin chromophore (Profio & Balchum, 1985; Unsold et al., 1990) . The latter application is presently limited by two main factors: (i) the degree of selectivity of tumour labelling by the porphyrin is limited, because the ratio of photosensitiser concentration in the tumour to the peritumoral tissue often does not exceed 2-3:1 ; and (ii) the persistence of appreciable levels of photosensitivity in several tissues, including skin, for several weeks after systemic administration of the porphyrin (Dougherty, 1987) . Therefore, the development of safe and reliable photodiagnostic procedures requires the availability of highly fluorescent selective tumour localisers which are devoid of any appreciable photosensitising activity.
In this paper, we demonstrate the use of carotenoporphyrins (see Figure 1 ) as tumour-specific photodiagnostic agents. These compounds possess absorption spectra which essentially represent the sum of typical spectra of unlinked meso-substituted porphyrins and carotenes (Dirks et al., 1980) . The two-banded fluorescence spectrum (peaks at 655 and 720 nm) is again typical of porphyrins, with little or no contribution from the carotene. The covalent attachment of the carotene moiety to the porphyrin macrocycle through properly selected linkers ensures an electronic interaction between the i systems of the two chromophores, leading to an efficient quenching of the porphyrin triplet state by an energy transfer process. The porphyrin triplet state is the most reactive intermediate in porphyrin-photosensitised processes (Moore et al., 1982; Gust et al., 1992a) . The generation of singlet molecular oxygen ('02), which is a highly cytotoxic species, is an important reaction arising from the porphyrin triplet state. Moreover, via the energy transfer process:
'02 + Car-302 + 3Car, carotenoids could deactivate any singlet oxygen which may have escaped carotene quenching (Cogdell & Frank, 1987) . On the other hand, structural and energetic factors preclude the efficient carotene quenching of the porphyrin first excited singlet state, from which fluorescence originates (Gust et al., 1992a Thus, carotenoporphyrins possess unique photophysical and spectroscopic properties which make these compounds potentially suitable as in vivo diagnostic agents.
Materials and methods

Chemicals
The porphyrins and carotenoporphyrins were synthesised at Arizona State University following procedures previously described (Gust et al., 1992b High-performance liquid chromatography (HPLC) analyses Samples of porphyrin and carotenoporphyrin were analysed by normal-phase HPLC. Typcially, CP(Me)3 and the corresponding porphyrin P(Me)3 were dissolved in dichloromethane and eluted with dichloromethane through a silica gel column at a flow rate of 0.5 ml min i, using a Perkin-Elmer, Series 4, HPLC apparatus. The eluate was monitored at 420 nm, the absorption maximum of CP(Me)3 and P(Me)3. Liver and tumour extracts in chloroform-methanol, obtained from mice at 24 h after injection of CP(Me)3 (4.2 gimol kg-'), were taken to dryness by a rotary evaporator, resuspended in dichloromethane (1 ml), and eluted through the HPLC column in an analogous manner.
Photosensitisation studies Tumour-bearing mice were injected with 8.4 or 16.8 ,mol kg-1 P(Me)3 or CP(Me)3, and after 24 h the tumour area was irradiated with red light (600-700 nm) isolated by optical
filters from the emission of a 250 W halogen lamp, equipped with a bundle of optical fibres (external diameter 0.6 cm). 
Results
Pharmacokinetic studies
The analysis of the sera taken from mice at different times after the administration of CP(Me)3 or CP(OMe)3 showed that both carotenoporphyrins are cleared from the bloodstream in about 1 week (see Figure 2 ). After this time interval, only traces of carotenoporphyrin could be detected in the serum samples. The fractionation of the serum proteins at 3 and 24 h after the administration of 4.2 imol kg-' CP(Me)3 showed that this carotenoporphyrin is almost exclusively bound to lipoproteins (Table I) . Only negligible amounts of carotenoporphyrin were recovered from fraction 5, which includes albumin and globulins. However, the delivery of the carotenoporphyrin from Cremophor micelles to serum proteins appears to be a slow process. As can be seen in Table I , at 3 h after administration, c. 76% of CP(Me)3 is still retained in the Cremophor micelles.
*The identification of fraction 2 as Cremophor is based on the following considerations: (i) the fraction is not observed in sera obtained from animals not injected with Cremophor; (ii) the intensity of the band strongly decreases between 3 h and 24 h after injection in correspondence with the clearance of Cremophor from serum; and (iii) the fraction is not stained by Sudan black, which readily stains lipoproteins. The last finding rules out the possibility that fraction 2 contains some lipoproteins with a modifed density owing to interaction with Cremophor. The time dependency of CP(OMe)3 biodistribution in selected tissues of mice bearing the MS-2 fibrosarcoma is shown in Figure 3a and b for dye doses of 4.2 and 8.4 tLmol kg-' respectively. In both cases, the largest amounts of carotenoporphyrins were recovered from liver and spleen, as is typical of several hydrophobic porphyrin derivatives that are eliminated from the organism largely by the bile-gut pathway (Jori, 1987) . Amounts of CP(OMe)3 smaller than those found in liver and spleen were accumulated by tumour tissue, especially at the lower carotenoporphyrin dose. The maximal recoveries of CP(OMe)3 from the tumour were found at 24 h after administration and were found to be 8.7
and 38 glg g-' for the injected doses of 4.2 and 8.4 lmol kg-' respectively. Consistently low (< 2 fig g-1) amounts of CP(OMe)3 were found in skin and muscle at all time intervals. The pharmacokinetic behaviour of CP(Me)3 and the two parent porphyrins P(OMe)3 and P(Me)3 was very similar to that observed for CP(OMe)3. In Figure 4 we show the recoveries of P(OMe)3 from various tissues after administration of 4.2 pmol kg-1. Once again, large amounts of porphyrin were recovered from the components of the reticuloendothelial system, while maximal porphyrin accumulation in the tumour (c. 10.41ggg-1) occurred at 24h after administration; moreover, low amounts of the porphyrin were found in muscle and skin. The ratio of dye concentration in the tumour to that in the muscle at 24 h after injection is shown in Table II for CP(OMe)3, CP(Me)3, P(OMe)3 and P(Me)3; this parameter represents an index of the selectivity of tumour targeting because the muscle is the peritumoral tissue in our animal model. concentration does not undergo any appreciable decrease with time, especially from the liver. Selected liver extracts which contained appreciable concentrations of carotenoporphyrins were analysed by absorption spectroscopy in the visible spectral region: the position of the absorption bands characteristic of the carotene and porphyrin moieties were essentially identical to those typical of a carotenoporphyrin in a 2:1 methanol-chloroform solution. The high-performance liquid chromatogram of liver and tumour extracts from mice injected with CP(Me)3 showed a single component absorbing at 420 nm, whose retention time (t = 6.96 min) was coincident with that found for CP(Me)3; under the same conditions, P(Me)3 exhibited a retention time of 11.24 min.
Photosensitisation studies
Tumour-bearing mice were injected with 8.4 or 16.8 pmol kg-' P(Me)3 or CP(Me)3, and after 24 h the tumour was artwork:
irradiated with red light. The analysis of the tumour tissue performed at 24 h after irradiation showed the formation of a necrotic area (21.5 mm2) only in the tumours treated with P(Me)3. On the contrary, the tumour irradiated in the presence of CP(Me)3 did not show any necrosis. The tumours that received only light or were not treated also showed no necrosis.
Discussion
Our data show that the two meso-substituted porphyrins and the corresponding carotenoporphyrins studied in the present investigation are efficient tumour localisers. The pharmacokinetic behaviour of these compounds is typical of porphyrinoids administered in vivo by means of hydrophobic delivery systems, including the large accumulation in components of the reticuloendothelial system, and the relatively slow increase of dye concentration in the tumour, which reaches a maximum value c. 24 h after i.v. administration. On the other hand, some interesting features are the fast elimination of the carotenoporphyrins from serum, as compared with the persistence of appreciable amounts of Photofrin in mouse serum for several weeks (Bellnier et al., 1989) , as well as the notably low amounts of dye which were found in muscle and skin throughout our observation period.
The low levels of drug in skin should minimise the risk of general cutaneous photosensitivity induced by P(Me)3 or P(OMe)3, which are characterised by a good photosensitising activity (see Gust et al., 1992a , and our tumour photosensitisation studies). Skin photodamage is a well-established side effect of photodynamic therapy of tumours performed with Photofrin, which limits the use of this porphyrin as a photodiagnostic agent (Dougherty, 1987) . The rapid clearance of both porphyrins and carotenoporphyrins from serum further serves to decrease the probability of long-term skin photosensitivity (Bugelski et al., 1981) . Moreover, unusually large tumour/muscle concentration ratios of porphyrin or carotenoporphyrin are observed at various time intervals, and in particular at 24 h after injection (Table II ). Such a high selectivity level appears to be a property of the porphyrins (especially the trimethoxy-substituted compounds) and is independent of the injected dose. This finding is in agreement with previous observations (Winkelman, 1985; Bonnett & Berenbaum, 1990) indicating that meso-substituted porphyrins are excellent tumour localisers. The addition of the carotene moiety decreases the above-mentioned ratio, although the selectivity of tumour targeting remains remarkably high. This selectivity may be related to the essentially complete association of carotenoporphyrins with the lipoprotein class of serum proteins (Table I ). In the lipoprotein family, LDL has been claimed to play a major role in the transport and release of photosensitising agents to tumour cells (Maziere et al., 1990; Jori, 1992) . However, this is only a partial explanation because other porphyrin analogues, such as phthalocyanines and naphthalocyanines, which are specifically carried by serum lipoproteins, yield a less pronounced tumour selectivity (Reddi et al., 1990; Cuomo et al., 1990) .
On the whole, carotenoporphyrins CP(Me)3 and CP(OMe)3 display several features which make them very promising photodiagnostic agents for tumours, including, the high degree of chemical purity, the efficient fluorescence emission in the red spectral interval and their marked affinity for tumours. This prospect obviously needs to be further supported by extending our studies to tumour models more closely related to the clinical situation, such as colonic or oesophageal tumours. The photodiagnostic potential of carotenoporphyrins is greatly enhanced by their photochemical inertness under conditions where their porphyrin analogue causes readily detectable photodamage. This lack of photodynamic activity is certainly a consequence of the efficient quenching of the porphyrin triplet by the covalently bound and suitably spaced carotene. Thus, larger amounts of carotenoporphyrin can be injected, thereby facilitating the detection of the emitted fluorescence, without any risk of inducing photosensitising processes. This favourable situation is unlikely to be modifed by a time-dependent metabolic alteration of the carotene moiety, which might regenerate the photosensitising activity of the porphyrin. Our spectroscopic and HPLC studies of liver extracts seem to rule out any important change in the chemical structure of the carotenoporphyrins.
One possible drawback of the use of carotenoporphyrins in vivo may be the large amounts of dye which are accumulated by the liver and are retained for at least 2 months with no apparent trend toward elimination. In principle, this could lead to the onset of toxic effects and interference with some liver functions. A slow rate of dye release from liver has been previously observed for the aggregated constitutents of Photofrin (Bugelski et al., 1981) and some poorly watersoluble phthalocyanines and naphthalocyanines (Jori & Reddi, 1991) . However, in all these cases, the dye concentration in the liver gradually diminishes as a function of time, contrary to what was observed for the carotenoporphyrins. Recent findings from our laboratory (Cuomo et al., 1991) suggest a possible correlation between the hydrophobicity of a dye and the rate of its release from liver; in particular the release is accelerated by the addition of butoxy substituents to the phthalocyanine macrocycle. However, in the case of carotenoporphyrins, the replacement of the methyl groups by the somewhat more polar methoxy substituents has no appreciable effect on liver clearance. In our opinion, this problem needs to be adequately addressed if carotenoporphyrins are to be proposed for tumour photodiagnosis at the clinical level. Towards this end, we are exploring the effect of selected manipulation of the porphyrin and carotene structure.
